Predictive Biosciences
Founded 2003 · 4 employees on LinkedIn · 2 known investors
Find your way into Predictive Biosciences
Sign up to see every warm intro you have to Predictive Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Predictive Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DrugPatentWatch provides biopharmaceutical intelligence drawn from primary sources such as the USPTO, FDA Orange Book, ANDA filings, litigation records, and patent registers across 134 countries, covering drug patents, pipelines, litigation, and pricing. It serves pharmaceutical professionals including generics manufacturers, biotech firms, and distributors, offering continuously updated, exportable data for competitive and market analysis.
Founders & leadership
Predictive Biosciences was founded in 2003 by Yali Friedman.
Investors · 2
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Predictive Biosciences do?
- DrugPatentWatch provides biopharmaceutical intelligence drawn from primary sources such as the USPTO, FDA Orange Book, ANDA filings, litigation records, and patent registers across 134 countries, covering drug patents, pipelines, litigation, and pricing. It serves pharmaceutical professionals including generics manufacturers, biotech firms, and distributors, offering continuously updated, exportable data for competitive and market analysis.
- Who founded Predictive Biosciences?
- Predictive Biosciences was founded by Yali Friedman in 2003.
- Who are Predictive Biosciences's investors?
- Predictive Biosciences's investors include New Enterprise Associates (NEA), Kaiser Permanente Ventures.
